 Diagnosis nasopharyngeal carcinoma means recombinant Epstein-Barr virus proteins immune response patients nasopharyngeal carcinoma Epstein-Barr virus EBV diagnostic tumour tests EBV antigens EBV-infected lymphoblastoid cells virus cells Serum patients nasopharyngeal carcinoma western blot analysis enzyme-linked immunosorbent assay ELISA immunofluorescence tests antibodies EBV-coded alkaline deoxyribonuclease DNase thymidine kinase membrane antigen recombinant baculovirus bovine papillomavirus systems protein useful diagnostic marker nasopharyngeal carcinoma ELISAs substantial overlap IgG IgA antibodies serum samples nasopharyngeal carcinoma patients healthy donors EBV EBV thymidine kinase sensitive predictor nasopharyngeal carcinoma samples IgG IgA antibody protein distinct titres EBV-seropositive donors IgA test recombinant systems suitable use large-scale screening programmes early diagnosis nasopharyngeal carcinoma